colloidal silicon dioxide

DRUG4 trials

Sponsors

University Medical Center Utrecht, Karolinska Institutet, Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL, Ankara Etlik City Hospital

Conditions

Acute ischemic strokeMonkeypoxPatients with major depressive episode and moderate to severe insomnia disorderUrticaria Acute

Phase 3

A phase 3, randomised, double-blind, placebo-controlled, parallel-arm efficacy trial of Imatinib in acute ischaemic stroke

SuspendedCTIS2023-506178-11-00

Karolinska InstitutetAcute ischemic stroke

Start: 2025-11-11Target: 680Updated: 2023-11-07

Phase 4

European Randomised Clinical Trial on mPOX Infection (EPOXI)

CompletedCTIS2022-501979-10-00

University Medical Center UtrechtMonkeypox

Start: 2024-08-08End: 2025-07-14Target: 335Updated: 2025-06-26

Efficacy and Safety of Daridorexant in Patients with Major Depressive Disorder (MDD) and Insomnia: Double-blind, randomized, controlled trial

Not yet recruitingCTIS2025-524794-16-00

Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELLPatients with major depressive episode and moderate to severe insomnia disorder

Target: 134Updated: 2026-05-04

Unknown Phase

Oral Colloidal Silicon Dioxide Added to Routine Treatment for Acute Urticaria in the Emergency Department

CompletedNCT07866092

Ankara Etlik City HospitalUrticaria Acute

Start: 2026-08-24End: 2026-10-01Updated: 2026-10-08